Hydroxychloroquine, Uses, Dosage, Side Effects, Interactions, Pregnancy

Hydroxychloroquine








User Review


5
(8 votes)


Hydroxychloroquine is a 4-aminoquinoline with immunosuppressive, antiautophagy, and antimalarial activities. Although the precise mechanism of action is unknown, hydroxychloroquine may suppress immune function by interfering with the processing and presentation of antigens and the production of cytokines. As a lysosomotropic agent, hydroxychloroquine raises intralysosomal pH, impairing autophagic protein degradation; hydroxychloroquine-mediated accumulation of ineffective autophagosomes may result in cell death in tumor cells reliant on autophagy for survival. In addition, this agent is highly active against the erythrocytic forms of P. vivax and malaria and most strains of P. falciparum but not the gametocytes of P. falciparum.

Hydroxychloroquine is a derivative of chloroquine that has both antimalarial and anti-inflammatory activities and is now most often used as an antirheumatologic agent in systemic lupus erythematosus and rheumatoid arthritis. Hydroxychloroquine therapy has not been associated with liver function abnormalities and is an extremely rare cause of clinically apparent acute liver injury.

Hydroxychloroquine (HCQ) is a lupus erythematosus (chronic discoid or systemic) and acute or chronic rheumatoid arthritis drug is a medication used for the prevention and treatment of certain types of malaria.

Mechanism of Action of Hydroxychloroquine

Although the exact mechanism of action is unknown, it may be based on the ability of hydroxychloroquine to bind to and alter DNA. Hydroxychloroquine has also has been found to be taken up into the acidic food vacuoles of the parasite in the erythrocyte. This increases the pH of the acid vesicles, interfering with vesicle functions and possibly inhibiting phospholipid metabolism. In suppressive treatment, hydroxychloroquine inhibits the erythrocytic stage of development of plasmodia. In acute attacks of malaria, it interrupts erythrocytic schizogony of the parasite. Its ability to concentrate in parasitized erythrocytes may account for their selective toxicity against the erythrocytic stages of plasmodial infection. As an antirheumatic, hydroxychloroquine is thought to act as a mild immunosuppressant, inhibiting the production of rheumatoid factor and acute phase reactants. It also accumulates in white blood cells, stabilizing lysosomal membranes and inhibiting the activity of many enzymes, including collagenase and the proteases that cause cartilage breakdown.

You Can Also Like   Cefoxitin; Indications/Uses, Dosage, Side Effects, Interactions

Indications of Hydroxychloroquine

  • Rheumatoid Arthritis
  • Juvenile idiopathic arthritis (in children)
  • Discoid and systemic lupus erythematosus (a disease of the skin or the internal organs)
  • Skin problems which are sensitive to sunlight
  • Lyme Disease, Arthritis
  • Dermatomyositis
  • Malaria
  • Systemic Lupus Erythematosus
  • Malaria Prevention
  • Sjogren’s Syndrome
  • Undifferentiated Connective Tissue Disease
  • Discoid Lupus Erythematosus
  • Malaria caused by Plasmodium malaria
  • Malaria caused by Plasmodium ovale
  • Malaria caused by plasmodium vivax
  • Porphyria Cutanea Tarda
  • Q Fever
  • Sjögren’s Syndrome
  • Systemic Lupus Erythematosus

Contra-Indications of Hydroxychloroquine

  • Hyper sense. to drug class common.
  • Retinal or visual field changes
  • Concurrent hepatotoxic agent use
  • Hepatic impairment
  • Alcoholism
  • Pediatric pts
  • Psoriasis
  • Porphyria
  • Electrolyte abnormalities
  • Congenital long QT syndrome
  • QT prolongation
  • QT prolongation family hx
  • Ventricular arrhythmias
  • Bradycardia

Dosage of Hydroxychloroquine

Strength: 200 mg, 400 mg

Lupus Erythematosus

  • Typical starting dosage: 400 mg taken once or twice per day.
  • Typical maintenance dosage: 200–400 mg per day.

Rheumatoid Arthritis

  • Initial dose: 400 to 600 mg (310 to 465 mg base) orally once a day to optimum response (usually 4 to 12 weeks)
  • Maintenance dose: 200 to 400 mg (155 to 310 mg base) orally once a day
  • Dose adjustment: The dose may need to be reduced temporarily if adverse side effects occur; after 5 to 10 days the dose may gradually be increased to the optimum response level.
  • Maintenance dose: 200 to 400 mg (155 mg to 310 mg base) orally daily

Arthritis

  • Typical starting dosage: 400–600 mg per day for 5–10 days.
  • Dosage increases: Your doctor may increase your dosage based on how well the medication is working for you.
  • Maintenance dosage: 4–12 weeks after your starting dose, your doctor may lower your dosage to 200–400 mg per day.
You Can Also Like   Iodine Deficiency Symptoms, Food Source, Health Benefit

Malaria

Adult dosage (ages 18 years and older)

  • The typical starting dose is 800 mg. This is followed by 400 mg three times: 6 hours after the first dose, 24 hours after the first dose, and 48 hours after the first dose.

Side Effects of Hydroxychloroquine

The more common side effects 

Common

Rare

Drug Interactions of Hydroxychloroquine

Hydroxychloroquine may interact with following drugs, supplements, & may change the efficacy of drugs

You Can Also Like   Anticholesterol Drug/Lipid Lowering Drug /Statins Groups Drug

 Hydroxychloroquine additional drug interaction

  • Some antibiotics used for infections (such as gentamicin, neomycin or tobramycin)
  • Cimetidine – used for stomach ulcers
  • Neostigmine and pyridostigmine – used for muscle weakness (myasthenia gravis)
  • Medicines that may affect the kidneys or liver
  • Medicines that affect the skin or the eyes
  • Halofantrine, mefloquine – used for malaria
  • Amiodarone – used for heart problems
  • Moxifloxacin – used to treat infections
  • Medicines used for epilepsy

Pregnancy & Lactation

FDA  Pregnancy Category D

Pregnancy

Use of chloroquine and other 4-aminoquinolines in high doses and for prolonged durations has been associated with neurological disturbances and interference with hearing, balance, and vision in the fetus. There are no controlled data in human pregnancy. Drugs which have caused, are suspected to have caused or may be expected to cause, an increased incidence of human fetal malformations or irreversible damage.

Lactation

Infants exposed to hydroxychloroquine during breastfeeding receive only small amounts of the drug in breastmilk. In a small number of infants up to at least 1 year of age, careful follow-up found no adverse effects on growth, vision or hearing. International experts indicate that hydroxychloroquine is acceptable during breastfeeding.

References

    • DrugBank

      http://www.drugbank.ca/drugs/DB01611
      http://www.drugbank.ca/drugs/DB01611#targets
      http://www.drugbank.ca/drugs/DB01611#enzymes

      https://www.drugs.com/hydroxychloroquine.html

    • EPA DSStox

      https://comptox.epa.gov/dashboard/dsstoxdb/results?search=DTXSID8023135

    • European Chemicals Agency (ECHA)

      https://echa.europa.eu/substance-information/-/substanceinfo/100.003.864

      https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/91823

      https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-oral/details/list-contraindications

    • Human Metabolome Database (HMDB)

      http://www.hmdb.ca/metabolites/HMDB0015549

    • ClinicalTrials.gov

      https://clinicaltrials.gov/

    • LiverTox

      https://livertox.nlm.nih.gov/Hydroxychloroquine.htm

    • NCIT

      https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C557

    • EU Community Register of Medicinal Products

      https://ec.europa.eu/health/documents/community-register/html/o1820.htm

    • FDA Orange Book

      https://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm

    • MassBank of North America (MoNA)

      http://mona.fiehnlab.ucdavis.edu/spectra/browse?inchikey=XXSMGPRMXLTPCZ-UHFFFAOYSA-N

    • SpectraBase
      https://spectrabase.com/compound/4inaBf89tkR#9oruUbDrn7m
      https://spectrabase.com/compound/4inaBf89tkR#D26gOcJJKt4
    • NIST

      http://www.nist.gov/srd/nist1a.cfm

    • PubMed Health

      http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010621/

Print Friendly, PDF & Email

Sharing to Spread to the World

4 thoughts on “Hydroxychloroquine, Uses, Dosage, Side Effects, Interactions, Pregnancy”

Leave a Reply

Your email address will not be published.